Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ)
CNY 6.89
(-0.14%)
CNY 6.89
(-0.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 94.73 Million CNY | 14.0% |
| 2022 | 83.09 Million CNY | -13.46% |
| 2021 | 96.02 Million CNY | 19.94% |
| 2020 | 80.06 Million CNY | 4.52% |
| 2019 | 76.59 Million CNY | 10.89% |
| 2018 | 69.07 Million CNY | 15.0% |
| 2017 | 60.06 Million CNY | 355.27% |
| 2016 | 13.19 Million CNY | 20.92% |
| 2015 | 10.91 Million CNY | -88.68% |
| 2014 | 96.4 Million CNY | 10.41% |
| 2013 | 87.31 Million CNY | -9.63% |
| 2012 | 96.62 Million CNY | 0.15% |
| 2011 | 96.48 Million CNY | 10.09% |
| 2010 | 87.63 Million CNY | 43.37% |
| 2009 | 61.12 Million CNY | 47.77% |
| 2008 | 41.36 Million CNY | 14.56% |
| 2007 | 36.1 Million CNY | 53.84% |
| 2006 | 23.47 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 12.31 Million CNY | -41.38% |
| 2024 Q1 | 21.01 Million CNY | -42.04% |
| 2024 Q3 | 2.52 Million CNY | -79.47% |
| 2023 Q4 | 36.26 Million CNY | 228.43% |
| 2023 Q2 | 18.72 Million CNY | -34.76% |
| 2023 Q1 | 28.7 Million CNY | 26.09% |
| 2023 FY | 94.73 Million CNY | 14.0% |
| 2023 Q3 | 11.04 Million CNY | -41.04% |
| 2022 Q3 | 16.52 Million CNY | -0.37% |
| 2022 Q1 | 27.22 Million CNY | -11.5% |
| 2022 FY | 83.09 Million CNY | -13.46% |
| 2022 Q4 | 22.76 Million CNY | 37.78% |
| 2022 Q2 | 16.58 Million CNY | -39.1% |
| 2021 FY | 96.02 Million CNY | 19.94% |
| 2021 Q1 | 27.76 Million CNY | 7.32% |
| 2021 Q2 | 13.6 Million CNY | -51.0% |
| 2021 Q3 | 23.88 Million CNY | 75.51% |
| 2021 Q4 | 30.76 Million CNY | 28.85% |
| 2020 Q3 | 21.34 Million CNY | 87.89% |
| 2020 Q2 | 11.36 Million CNY | -47.12% |
| 2020 Q1 | 21.48 Million CNY | 0.93% |
| 2020 FY | 80.06 Million CNY | 4.52% |
| 2020 Q4 | 25.87 Million CNY | 21.21% |
| 2019 Q2 | 23.18 Million CNY | 37.39% |
| 2019 FY | 76.59 Million CNY | 10.89% |
| 2019 Q4 | 21.28 Million CNY | 39.48% |
| 2019 Q3 | 15.26 Million CNY | -34.16% |
| 2019 Q1 | 16.87 Million CNY | 5.78% |
| 2018 Q2 | 18.92 Million CNY | -7.03% |
| 2018 Q1 | 20.35 Million CNY | 26.82% |
| 2018 FY | 69.07 Million CNY | 15.0% |
| 2018 Q4 | 15.94 Million CNY | 15.18% |
| 2018 Q3 | 13.84 Million CNY | -26.83% |
| 2017 Q2 | 11.03 Million CNY | -39.79% |
| 2017 FY | 60.06 Million CNY | 355.27% |
| 2017 Q4 | 16.05 Million CNY | 9.47% |
| 2017 Q3 | 14.66 Million CNY | 32.91% |
| 2017 Q1 | 18.32 Million CNY | 202.17% |
| 2016 Q1 | 14.48 Million CNY | 124.16% |
| 2016 FY | 13.19 Million CNY | 20.92% |
| 2016 Q4 | -17.93 Million CNY | -390.69% |
| 2016 Q2 | 10.47 Million CNY | -27.7% |
| 2016 Q3 | 6.16 Million CNY | -41.09% |
| 2015 Q2 | 41.09 Million CNY | 191.7% |
| 2015 Q4 | -59.94 Million CNY | -482.45% |
| 2015 Q3 | 15.67 Million CNY | -61.86% |
| 2015 FY | 10.91 Million CNY | -88.68% |
| 2015 Q1 | 14.08 Million CNY | -50.81% |
| 2014 Q1 | 17.19 Million CNY | 12.68% |
| 2014 Q2 | 31.62 Million CNY | 83.87% |
| 2014 Q4 | 28.64 Million CNY | 51.16% |
| 2014 FY | 96.4 Million CNY | 10.41% |
| 2014 Q3 | 18.94 Million CNY | -40.08% |
| 2013 Q1 | 15.67 Million CNY | -40.16% |
| 2013 Q2 | 32.15 Million CNY | 105.1% |
| 2013 Q3 | 24.22 Million CNY | -24.66% |
| 2013 Q4 | 15.26 Million CNY | -37.0% |
| 2013 FY | 87.31 Million CNY | -9.63% |
| 2012 FY | 96.62 Million CNY | 0.15% |
| 2012 Q4 | 26.19 Million CNY | 4.12% |
| 2012 Q2 | 30.76 Million CNY | 112.07% |
| 2012 Q3 | 25.16 Million CNY | -18.21% |
| 2012 Q1 | 14.5 Million CNY | -55.32% |
| 2011 Q3 | 23.38 Million CNY | -14.18% |
| 2011 FY | 96.48 Million CNY | 10.09% |
| 2011 Q4 | 32.46 Million CNY | 38.83% |
| 2011 Q1 | 13.39 Million CNY | -58.29% |
| 2011 Q2 | 27.24 Million CNY | 103.46% |
| 2010 Q3 | 21.95 Million CNY | 0.66% |
| 2010 Q2 | 21.81 Million CNY | 85.53% |
| 2010 FY | 87.63 Million CNY | 43.37% |
| 2010 Q1 | 11.75 Million CNY | 0.0% |
| 2010 Q4 | 32.1 Million CNY | 46.19% |
| 2009 FY | 61.12 Million CNY | 47.77% |
| 2008 FY | 41.36 Million CNY | 14.56% |
| 2007 FY | 36.1 Million CNY | 53.84% |
| 2006 FY | 23.47 Million CNY | 0.0% |